Följ
David M Brown MD FACS
David M Brown MD FACS
Director of Research, Retina Consultants of Houston
Verifierad e-postadress på houstonretina.com - Startsida
Titel
Citeras av
Citeras av
År
Ranibizumab for neovascular age-related macular degeneration
PJ Rosenfeld, DM Brown, JS Heier, DS Boyer, PK Kaiser, CY Chung, ...
New England Journal of Medicine 355 (14), 1419-1431, 2006
7543*2006
Ranibizumab for neovascular age-related macular degeneration
PJ Rosenfeld, DM Brown, JS Heier, DS Boyer, PK Kaiser, CY Chung, ...
New England Journal of Medicine 355 (14), 1419-1431, 2006
69592006
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
DM Brown, PK Kaiser, M Michels, G Soubrane, JS Heier, RY Kim, JP Sy, ...
New England Journal of Medicine 355 (14), 1432-1444, 2006
43252006
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
DM Brown, PK Kaiser, M Michels, G Soubrane, JS Heier, RY Kim, JP Sy, ...
New England Journal of Medicine 355 (14), 1432-1444, 2006
43252006
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
JS Heier, DM Brown, V Chong, JF Korobelnik, PK Kaiser, QD Nguyen, ...
Ophthalmology 119 (12), 2537-2548, 2012
25662012
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE
QD Nguyen, DM Brown, DM Marcus, DS Boyer, S Patel, L Feiner, ...
Ophthalmology 119 (4), 789-801, 2012
18692012
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study
DM Brown, M Michels, PK Kaiser, JS Heier, JP Sy, T Ianchulev
Ophthalmology 116 (1), 57-65. e5, 2009
17072009
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study
DM Brown, M Michels, PK Kaiser, JS Heier, JP Sy, T Ianchulev
Ophthalmology 116 (1), 57-65. e5, 2009
17072009
Structural-functional relationships in diabetic nephropathy.
SM Mauer, MW Steffes, EN Ellis, DE Sutherland, DM Brown, FC Goetz
The Journal of clinical investigation 74 (4), 1143-1155, 1984
15551984
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
DS Boyer, YH Yoon, R Belfort Jr, F Bandello, RK Maturi, AJ Augustin, ...
Ophthalmology 121 (10), 1904-1914, 2014
12282014
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study
PA Campochiaro, JS Heier, L Feiner, S Gray, N Saroj, AC Rundle, ...
Ophthalmology 117 (6), 1102-1112. e1, 2010
11692010
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1
CD Regillo, DM Brown, P Abraham, H Yue, T Ianchulev, S Schneider, ...
American journal of ophthalmology 145 (2), 239-248. e5, 2008
11272008
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study
DM Brown, PA Campochiaro, RP Singh, Z Li, S Gray, N Saroj, AC Rundle, ...
Ophthalmology 117 (6), 1124-1133. e1, 2010
10612010
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE
DM Brown, QD Nguyen, DM Marcus, DS Boyer, S Patel, L Feiner, ...
Ophthalmology 120 (10), 2013
10242013
Intravitreal aflibercept for diabetic macular edema
JF Korobelnik, DV Do, U Schmidt-Erfurth, DS Boyer, FG Holz, JS Heier, ...
Ophthalmology 121 (11), 2247-2254, 2014
9972014
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies
U Schmidt-Erfurth, PK Kaiser, JF Korobelnik, DM Brown, V Chong, ...
Ophthalmology 121 (1), 193-201, 2014
9262014
Identification of novel genes in Arabidopsis involved in secondary cell wall formation using expression profiling and reverse genetics
DM Brown, LAH Zeef, J Ellis, R Goodacre, SR Turner
The Plant Cell 17 (8), 2281-2295, 2005
8602005
HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration
PU Dugel, A Koh, Y Ogura, GJ Jaffe, U Schmidt-Erfurth, DM Brown, ...
Ophthalmology 127 (1), 72-84, 2020
7622020
Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema
Diabetic Retinopathy Clinical Research Network
Ophthalmology 114 (3), 525-536, 2007
7072007
Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies
DM Brown, U Schmidt-Erfurth, DV Do, FG Holz, DS Boyer, E Midena, ...
Ophthalmology 122 (10), 2044-2052, 2015
6422015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20